AMP Files Lawsuit Against FDA to Challenge LDT Final Rule
The lawsuit challenges the FDA rule that regulates LDTs as medical devices, arguing that the FDA lacks authority to impose such regulations.
Read MorePosted by Andy Lundin | Aug 19, 2024 | Miscellaneous |
The lawsuit challenges the FDA rule that regulates LDTs as medical devices, arguing that the FDA lacks authority to impose such regulations.
Read MorePosted by Andy Lundin | Aug 19, 2024 | Sequencing Systems |
Ambry Genetics unveiled a new multiomic exome sequencing test that incorporates RNA analysis to enhance the detection of rare diseases.
Read MorePosted by Andy Lundin | Aug 16, 2024 | Prostate |
A newly discovered class of RNA molecules in extracellular vesicles could serve as biomarkers for non-invasive cancer diagnosis.
Read MorePosted by Andy Lundin | Aug 14, 2024 | Sequencing Systems |
GeneDx announced enhancements to its whole genome sequencing services, all aimed at accelerating diagnoses and improving health outcomes.
Read MorePosted by Chris Wolski | Aug 7, 2024 | Gastrointestinal Infections |
Researchers have developed a portable, rapid water testing technology to detect Shiga toxigenic Escherichia coli (STEC) bacteria.
Read More